Holen Sie sich die Stockscreener-App
0.9055
2.11%
-0.0195
Handel nachbörslich:
.91
0.0045
+0.50%
Schlusskurs vom Vortag:
$0.925
Offen:
$0.9331
24-Stunden-Volumen:
61,437
Relative Volume:
0.62
Marktkapitalisierung:
$23.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-39.22M
KGV:
-0.5104
EPS:
-1.7742
Netto-Cashflow:
$-17.31M
1W Leistung:
-5.15%
1M Leistung:
-0.49%
6M Leistung:
-7.01%
1J Leistung:
+83.30%
1-Tages-Spanne:
$0.9005
$0.96
1-Wochen-Bereich:
$0.88
$1.03
52-Wochen-Spanne:
$0.43
$1.45
AEON Biopharma Inc. Stock (AEON) Company Profile
Firmenname
AEON Biopharma Inc.
Sektor
Branche
Telefon
(949) 354-6499
Adresse
5 Park Plaza, Suite 1750, Irvine
Compare AEON vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.9055 | 24.33M | 0 | -39.22M | -17.31M | -1.7742 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-08-18 | Eingeleitet | H.C. Wainwright | Buy |
AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten
AEON Technical Analysis | Trend, Signals & Chart Patterns | AEON BIOPHARMA INC (NYSEARCA:AEON) - ChartMill
AEON Biopharma (AEON) details 2026 meeting, director elections and KPMG ratification - Stock Titan
AEON Stock Price, Quote & Chart | AEON BIOPHARMA INC (NYSEARCA:AEON) - ChartMill
AEON Biopharma Sets Annual Shareholder Meeting - The Manila Times
AEON cites going concern audit note, cash into Q3 2026 - Stock Titan
AEON Biopharma receives additional NYSE American non-compliance notice - MSN
AEON Bio (AEON) Stock: Why Brand Strength (Eye on Rally) 2026-04-20Market Movers - Cổng thông tin điện tử tỉnh Tây Ninh
Migraine Market: Pharma Pipeline Fuels Rapid Expansion by 2034 – DelveInsight | Eli Lilly and Company, Axsome Therapeutics, AEON Biopharma, Charleston Laboratories, Amgen, Teva Pharma, Anne Lindblad - Barchart.com
AEON (AEON Biopharma) PB Ratio : (As of Apr. 10, 2026) - GuruFocus
Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN
Weekly Earnings: Will AEON Biopharma Inc be affected by tariffs2026 Big Picture & High Conviction Investment Ideas - baoquankhu1.vn
What is the bull case for AEON Bio (AEON) Stock | AEON Q4 2025 Earnings: AEON Biopharma Inc. misses EPS, no revenue postedExpert Stock Picks - Newser
Is AEON Bio (AEON) Stock Rebounding | Price at $0.90, Up 1.27%Crowd Consensus Signals - Cổng thông tin điện tử tỉnh Tây Ninh
AEON Biopharma Receives NYSE American Non-Compliance Notice Due to Stockholders’ Equity Deficit and Ongoing Listing Challenges - Minichart
AEON Biopharma Receives Additional NYSE American Noncompliance Notice - The Globe and Mail
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times
AEON Biopharma, Inc. (AEON) stock price, news, quote and history - Yahoo Finance Singapore
AEON Biopharma Receives Second NYSE American Notice for Listing Non-Compliance - geneonline.com
AEON (AEON) CFO awarded 754,717 restricted stock units vesting over four years - Stock Titan
AEON Biopharma (AEON) CFO John Bencich files initial insider ownership report - Stock Titan
AEON Biopharma Faces Listing Compliance Risk - Intellectia AI
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards - The Manila Times
AEON Biopharma Received Notice of Noncompliance - TradingView — Track All Markets
New AEON finance chief gets stock awards tied to NYSE compliance - Stock Titan
Form 8-KCurrent report - ADVFN
AEON stays on NYSE despite $55 million deficit as deadline nears - Stock Titan
AEON Q4 2025 Earnings: AEON Biopharma Inc. Posts Big EPS Miss, No Revenue - Newser
AEON Forecast, Price Target & Analyst Ratings | AEON BIOPHARMA INC (NYSEARCA:AEON) - ChartMill
AEON Biopharma 2025 Financial Review - AlphaStreet
Stock Market Recap: Whats the profit margin of AEON Biopharma Inc - baoquankhu1.vn
AEON Biopharma reports biosimilar progress, secures financing By Investing.com - Investing.com Australia
AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program - The Manila Times
Can AEON Biopharma Inc keep up with sector leaders2026 Price Swings & AI Powered Market Entry Strategies - baoquankhu1.vn
AEON Biopharma 2025 10-K: Net loss $39.2M, EPS $(3.95) - TradingView — Track All Markets
AEON Biopharma (AEON) advances Botox biosimilar plan but warns on going concern - Stock Titan
AEON Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
[8-K] AEON Biopharma, Inc. Reports Material Event - Stock Titan
AEON Biopharma reports biosimilar progress, secures financing - Investing.com
AEON's Botox biosimilar matched 3,400 amino acids as FDA mapped next steps - Stock Titan
Latest AEON NewsAEON Biopharma Presents Positive Results fr... - Stock Titan
AEON Biopharma, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Biotech Landscape Update: Regulatory Approvals and Mergers - Intellectia AI
Aeon Biopharma announces FDA feedback after Type 2a meeting - Yahoo Finance
AEON Biopharma receives FDA feedback on botulinum toxin biosimilar - Investing.com
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program - The Manila Times
FDA maps next steps for AEON's bid to bring a Botox biosimilar - Stock Titan
AEON Biopharma (AEON) Projected to Post Quarterly Earnings on Wednesday - Defense World
If You Invested $1,000 in Aeon Biopharma (AEON) - Stock Titan
AEON Biopharma, Inc.: Fundamental Analysis and Financial Ratings | AEON | US00775E1029 - marketscreener.com
Technical Analysis: Whats the profit margin of AEON Biopharma Inc2026 WrapUp & Weekly Market Pulse Updates - baoquankhu1.vn
Travel Stocks: How much upside does AEON Biopharma Inc haveQuarterly Trade Summary & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Finanzdaten der AEON Biopharma Inc.-Aktie (AEON)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.77%
0.25%
Kapitalisierung:
|
Volumen (24h):